Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Murdoch IG, Jacobs TG, Nieuwenhuize RM, van Rossum-Schornagel QC, Schurink CAM, van Erp NP, Burger DM. Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity? AIDS 2022;36:322-323. [PMID: 34934024 DOI: 10.1097/qad.0000000000003115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]

For:	Murdoch IG, Jacobs TG, Nieuwenhuize RM, van Rossum-Schornagel QC, Schurink CAM, van Erp NP, Burger DM. Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity? AIDS 2022;36:322-323. [PMID: 34934024 DOI: 10.1097/qad.0000000000003115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]

Number

Cited by Other Article(s)

Giacomelli A, Cattaneo D, Pozza G, Moschese D, Cossu MV, Dalu D, Gervasoni C. Fostemsavir to overcome drug-drug interactions in heavily treatment-experienced people with HIV and cancer. J Antimicrob Chemother 2024:dkae121. [PMID: 38661237 DOI: 10.1093/jac/dkae121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/26/2024] Open